BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31037608)

  • 1. Comparison of wait times across the breast cancer treatment pathway among screened women undergoing organized breast assessment versus usual care.
    Blackmore KM; Weerasinghe A; Holloway CMB; Majpruz V; Mirea L; O'Malley FP; Paroschy Harris C; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D; Chiarelli AM
    Can J Public Health; 2019 Oct; 110(5):595-605. PubMed ID: 31037608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
    Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
    Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer.
    Smith CR; Chiarelli AM; Holloway CM; Mirea L; O'Malley FP; Blackmore KM; Pandya A; Majpruz V; Harris CP; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D
    Breast; 2018 Oct; 41():25-33. PubMed ID: 29957557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with wait times across the breast cancer treatment pathway in Ontario.
    Plotogea A; Chiarelli AM; Mirea L; Prummel MV; Chong N; Shumak RS; O'Malley FP; Holloway CM;
    Springerplus; 2013; 2():388. PubMed ID: 24255823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program.
    Chiarelli AM; Mai V; Halapy EE; Shumak RS; O'Malley FP; Klar NS
    Can J Public Health; 2005; 96(4):259-63. PubMed ID: 16625791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.
    Habbous S; Homenauth E; Barisic A; Kandasamy S; Majpruz V; Forster K; Yurcan M; Chiarelli AM; Groome P; Holloway CMB; Eisen A
    CMAJ Open; 2022; 10(2):E313-E330. PubMed ID: 35383035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Patient-Centered Approach to Wait Times in the Surgical Management of Breast Cancer in the Province of Ontario.
    Cordeiro E; Dixon M; Coburn N; Holloway CM
    Ann Surg Oncol; 2015 Aug; 22(8):2509-16. PubMed ID: 25564166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual Mammographic Screening Reduces the Risk of Interval or Higher Stage Invasive Breast Cancers Among Postmenopausal Women in the Ontario Breast Screening Program.
    Blackmore KM; Chiarelli AM; Mirea L; Mittmann N; Muradali D; Rabeneck L; Done SJ
    Can Assoc Radiol J; 2022 Aug; 73(3):524-534. PubMed ID: 35068172
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.
    Eisen A; Blackmore KM; Meschino WS; Muradali D; Carroll JC; Majpruz V; Warner E; Rabeneck L; Chiarelli AM
    Mol Genet Genomic Med; 2018 Mar; 6(2):213-223. PubMed ID: 29368425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Care Continuity and Wait Times to Receiving Breast Cancer Chemotherapy: A Population-Based Retrospective Cohort Study Using CanIMPACT Data.
    Walsh RL; Lofters A; Moineddin R; Krzyzanowska M; Grunfeld E
    Curr Oncol; 2021 Nov; 28(6):4786-4804. PubMed ID: 34898582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wait times for breast cancer surgery: effect of magnetic resonance imaging and preoperative investigations on the diagnostic pathway.
    Nessim C; Winocour J; Holloway DP; Saskin R; Holloway CM
    J Oncol Pract; 2015 Mar; 11(2):e131-8. PubMed ID: 25670200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving work-up of the abnormal mammogram through organized assessment: results from the ontario breast screening program.
    Quan ML; Shumak RS; Majpruz V; Holloway CM; O'Malley FP; Chiarelli AM
    J Oncol Pract; 2012 Mar; 8(2):107-12. PubMed ID: 23077438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program.
    Gold N; Christensen RAG; Arneja J; Aminoleslami A; Anderson GM; Brooks JD
    Breast Cancer Res Treat; 2023 Apr; 198(3):523-533. PubMed ID: 36800117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Longitudinal Analysis of Wait Times for Bariatric Surgery in a Publicly Funded, Regionalized Bariatric Care System.
    Doumouras AG; Albacete S; Mann A; Gmora S; Anvari M; Hong D
    Obes Surg; 2020 Mar; 30(3):961-968. PubMed ID: 31705416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer diagnosis and treatment wait times in specialized diagnostic units compared with usual care: a population-based study.
    Webber C; Whitehead M; Eisen A; Holloway CMB; Groome PA
    Curr Oncol; 2020 Aug; 27(4):e377-e385. PubMed ID: 32905256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.
    Jiang L; Gilbert J; Langley H; Moineddin R; Groome PA
    Health Promot Chronic Dis Prev Can; 2018 Oct; 38(10):358-367. PubMed ID: 30303656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic factors associated with diagnostic wait times by breast cancer detection method.
    Plotogea A; Chiarelli AM; Mirea L; Prummel MV; Chong N; Shumak RS; O'Malley FP; Holloway CM;
    Springerplus; 2014; 3():125. PubMed ID: 24741470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient navigation reduces time to care for patients with breast symptoms and abnormal screening mammograms.
    McKevitt E; Dingee C; Warburton R; Pao JS; Brown CJ; Wilson C; Kuusk U
    Am J Surg; 2018 May; 215(5):805-811. PubMed ID: 29352569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The wait time creep: changes in the surgical wait time for women with uterine cancer in Ontario, Canada, during 2000-2009.
    O'Leary E; Elit L; Pond G; Seow H
    Gynecol Oncol; 2013 Oct; 131(1):151-7. PubMed ID: 23838037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.